Scion Asset Management’s Biogen BIIB Stock Holding History

Scion Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$3.01M	–	16
2018 Q4	$3.01M	Buy	+10,000	New	+$3.19M	2.91%	14

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Scion Asset Management's BIIB Position: Q1 2019 in Review

Scion Asset Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 10,000 shares — an estimated $3.01M sold.

Scion Asset Management first reported a position in BIIB in Q4 2018 and held it in 1 quarter. The position peaked at $3.01M in Q4 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Scion Asset Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Scion Asset Management sold 10,000 Biogen shares in Q1 2019, an estimated $3.01M.
Scion Asset Management first reported a position in Biogen in Q4 2018 and held it in 1 quarter.
Scion Asset Management's Biogen position peaked at $3.01M in Q4 2018.
1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Scion Asset Management's 13F filing for Q1 2019, filed 15 May 2019.